Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kay D. Rittenhouse
Observed names:
K RITTENHOUSE,
KAY D RITTENHOUSE,
Kay D Rittenhouse,
Kay Rittenhouse,
Rittenhouse, Kay D.
Institution:
Bayer (Switzerland)
Observed institutions:
University of North Carolina at Chapel Hill,
Bayer (United States),
Pfizer (United States),
Bayer (Switzerland),
ORCID,
Bausch + Lomb (United States)
show all 6
ORCID:
0000-0001-7503-5759
Observed ORCID:
0000-0001-7503-5759
OpenAlex ID:
A5007626265
VEGFR1 signaling in retinal angiogenesis and microinflammation
2021
·
Akiyoshi Uemura
, Marcus Fruttiger
, et al.
·
Progress in Retinal and Eye Research
·
355
PDF
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
2010
·
Henry F. Edelhauser
, Cheryl L. Rowe-Rendleman
, et al.
·
Investigative Ophthalmology & Visual Science
·
262
PDF
Drug and Gene Delivery to the Back of the Eye: From Bench to Bedside
2014
·
Cheryl L. Rowe-Rendleman
, Shelley A. Durazo
, et al.
·
Investigative Ophthalmology & Visual Science
·
120
Ocular Pharmacokinetics of Fluocinolone Acetonide After Retisert™ Intravitreal Implantation in Rabbits Over a 1-Year Period
2004
·
Jean-Yves Driot
, Gary D. Novack
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
100
Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease
2012
·
Jing-Feng Huang
, Rolla Yafawi
, et al.
·
Ophthalmology
·
79
PDF
Evaluations of Tear Protein Markers in Dry Eye Disease: Repeatability of Measurement and Correlation with Disease
2012
·
Jing-Feng Huang
, Yi Zhang
, et al.
·
Investigative Ophthalmology & Visual Science
·
67
Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models
2016
·
Anand Giddabasappa
, Kush Lalwani
, et al.
·
Experimental Eye Research
·
55
PDF
Local Tolerance and Systemic Safety of Pegaptanib Sodium in the Dog and Rabbit
2007
·
Jeffrey W.-D. Foy
, Kay Rittenhouse
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
52
Microdialysis and drug delivery to the eye
2000
·
Kay D Rittenhouse
, Gary M Pollack
·
Advanced Drug Delivery Reviews
·
51
Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition
1998
·
Kay D. Rittenhouse
, Robert L. Peiffer
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
51
Integrated results from the COPERNICUS and GALILEO studies
2017
·
Amelie Pielen
, W. Lloyd Clark
, et al.
·
Clinical ophthalmology
·
41
PDF
Microdialysis Evaluation of the Ocular Pharmacokinetics of Propranolol in the Conscious Rabbit
1999
·
Kay D. Rittenhouse
, Robert L. Peiffer
, et al.
·
Pharmaceutical Research
·
38
RTP801 Gene Expression Is Differentially Upregulated in Retinopathy and Is Silenced by PF-04523655, a 19-Mer siRNA Directed Against RTP801
2014
·
Kay D. Rittenhouse
, Theodore R. Johnson
, et al.
·
Investigative Ophthalmology & Visual Science
·
30
Retina Expression and Cross-Species Validation of Gene Silencing by PF-655, a Small Interfering RNA Against RTP801 for the Treatment of Ocular Disease
2012
·
Dong U. Lee
, Wenhu Huang
, et al.
·
Journal of Ocular Pharmacology and Therapeutics
·
25
The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost
2009
·
Belmira Lara da Silveira Andrade da Costa
, Kui Dong Kang
, et al.
·
Neurochemistry International
·
24
Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes
2021
·
Thomas Eissing
, Michael W. Stewart
, et al.
·
Translational Vision Science & Technology
·
21
Expression of Prostaglandin PGE 2 Receptors under Conditions of Aging and Stress and the Protective Effect of the EP2 Agonist Butaprost on Retinal Ischemia
2009
·
Neville N. Osborne
, Guang-Yu Li
, et al.
·
Investigative Ophthalmology & Visual Science
·
21
Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration
2015
·
Robyn Guymer
, Tania Cipriani
, et al.
·
Graefe s Archive for Clinical and Experimental Ophthalmology
·
16
Dose-Response Profile of PF-03187207 (PF-207) and Peak IOP Lowering Response Following Single Topical Administration to FP Receptor Knockout Mice vs. Wild Type Mice
2009
·
T. Saeki
, Hidekazu Tsuruga
, et al.
·
Investigative Ophthalmology & Visual Science
·
15
Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study
2023
·
Audrey Giocanti-Aurégan
, Simone Donati
, et al.
·
Ophthalmology and Therapy
·
12
PDF
Assessment of ascorbate ocular disposition in the conscious rabbit: An approach using the microdialysis technique
2000
·
Kay D. Rittenhouse
, Robert L. Peiffer
, et al.
·
Current Eye Research
·
12
Adverse Events Associated with Commonly Used Glaucoma Drugs
1999
·
Roger Vogel
, Ellen Strahlman
, et al.
·
International Ophthalmology Clinics
·
11
Evaluation of Molecular Properties versus In Vivo Performance of Aflibercept, Brolucizumab, and Ranibizumab in a Retinal Vascular Hyperpermeability Model
2022
·
William Schubert
, Carsten Terjung
, et al.
·
Translational Vision Science & Technology
·
10
Microdialysis assessment of drug delivery systems for vitreoretinal targets
2005
·
S DUVVURI
, K RITTENHOUSE
, et al.
·
Advanced Drug Delivery Reviews
·
10
Measuring Cone Density in a Japanese Macaque (Macaca fuscata) Model of Age-Related Macular Degeneration with Commercially Available Adaptive Optics
2014
·
Mark E. Pennesi
, Anupam K. Garg
, et al.
·
Advances in experimental medicine and biology
·
7
Show more works
View as search
Works count:
55
Citation count:
1,516
H-index:
17
I10-index:
24
Year
Topic
Type
